297 related articles for article (PubMed ID: 24918666)
21. Treatment of hereditary angioedema: a review (CME).
Bhardwaj N; Craig TJ
Transfusion; 2014 Nov; 54(11):2989-96; quiz 2988. PubMed ID: 24735226
[TBL] [Abstract][Full Text] [Related]
22. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
23. Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients.
Federici C; Perego F; Borsoi L; Crosta V; Zanichelli A; Gidaro A; Tarricone R; Cicardi M
BMJ Open; 2018 Jul; 8(7):e022291. PubMed ID: 30061443
[TBL] [Abstract][Full Text] [Related]
24. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
[TBL] [Abstract][Full Text] [Related]
25. Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States.
Riedl MA; Banerji A; Manning ME; Burrell E; Joshi N; Patel D; Machnig T; Tai MH; Watson DJ
Orphanet J Rare Dis; 2018 Oct; 13(1):180. PubMed ID: 30314518
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
[TBL] [Abstract][Full Text] [Related]
27. Icatibant for the treatment of hereditary angioedema.
Cole SW; Lundquist LM
Ann Pharmacother; 2013 Jan; 47(1):49-55. PubMed ID: 23249729
[TBL] [Abstract][Full Text] [Related]
28. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in management and treatment of hereditary angioedema.
Sardana N; Craig TJ
Pediatrics; 2011 Dec; 128(6):1173-80. PubMed ID: 22065270
[TBL] [Abstract][Full Text] [Related]
30. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
[TBL] [Abstract][Full Text] [Related]
31. Facilitating home-based treatment of hereditary angioedema.
Bernstein JA; Riedl M; Zacek L; Shapiro RS
Allergy Asthma Proc; 2015; 36(2):92-9. PubMed ID: 25551795
[TBL] [Abstract][Full Text] [Related]
32. Current treatment of hereditary angioedema: An update on clinical studies.
Banerji A
Allergy Asthma Proc; 2010; 31(5):398-406. PubMed ID: 20929607
[TBL] [Abstract][Full Text] [Related]
33. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies.
Schneider L; Hurewitz D; Wasserman R; Obtulowicz K; Machnig T; Moldovan D; Reshef A; Craig TJ
Pediatr Allergy Immunol; 2013 Feb; 24(1):54-60. PubMed ID: 23173714
[TBL] [Abstract][Full Text] [Related]
34. Hereditary angioedema: management of laryngeal attacks.
Christiansen SC; Zuraw BL
Am J Rhinol Allergy; 2011; 25(6):379-82. PubMed ID: 22185739
[TBL] [Abstract][Full Text] [Related]
35. Management and prevention of hereditary angioedema attacks.
Lumry WR
Am J Manag Care; 2013 Jun; 19(7 Suppl):s111-8. PubMed ID: 23844783
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with hospital admission in hereditary angioedema attacks: a multicenter prospective study.
Javaud N; Gompel A; Bouillet L; Boccon-Gibod I; Cantin D; Smaiti N; Carpentier F; Boubaya M; Launay D; Adnet F; Fain O
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):499-503. PubMed ID: 25935434
[TBL] [Abstract][Full Text] [Related]
37. Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema.
Piras V; Alves F; Gonçalo M
Dermatol Ther; 2019 Nov; 32(6):e13098. PubMed ID: 31579975
[TBL] [Abstract][Full Text] [Related]
38. [Hereditary angioedema--treatment].
Muszyńska A; Fal AM
Pol Merkur Lekarski; 2008 Jul; 25(145):94-6. PubMed ID: 18839625
[TBL] [Abstract][Full Text] [Related]
39. Icatibant as acute treatment for hereditary angioedema in adults.
Farkas H
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
[TBL] [Abstract][Full Text] [Related]
40. Managing hereditary angioedema patients undergoing otolaryngeal procedures.
Bernstein JA
Am J Rhinol Allergy; 2013; 27(6):522-7. PubMed ID: 23866957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
